Nothing Special   »   [go: up one dir, main page]

NO993738D0 - 2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia - Google Patents

2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia

Info

Publication number
NO993738D0
NO993738D0 NO993738A NO993738A NO993738D0 NO 993738 D0 NO993738 D0 NO 993738D0 NO 993738 A NO993738 A NO 993738A NO 993738 A NO993738 A NO 993738A NO 993738 D0 NO993738 D0 NO 993738D0
Authority
NO
Norway
Prior art keywords
lipoproteinemia
arteriosclerosis
hyper
amino
treatment
Prior art date
Application number
NO993738A
Other languages
Norwegian (no)
Other versions
NO993738L (en
Inventor
Carsten Schmeck
Arndt Brandes
Michael Loegers
Gunter Schmidt
Klaus-Dieter Bremm
Hilmar Bischoff
Delf Schmidt
Joachim Schuhmacher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO993738D0 publication Critical patent/NO993738D0/en
Publication of NO993738L publication Critical patent/NO993738L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO993738A 1997-02-05 1999-08-02 2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia NO993738L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19704243A DE19704243A1 (en) 1997-02-05 1997-02-05 New 2-amino-substituted pyridines
PCT/EP1998/000362 WO1998034920A1 (en) 1997-02-05 1998-01-23 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia

Publications (2)

Publication Number Publication Date
NO993738D0 true NO993738D0 (en) 1999-08-02
NO993738L NO993738L (en) 1999-09-17

Family

ID=7819326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993738A NO993738L (en) 1997-02-05 1999-08-02 2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia

Country Status (19)

Country Link
EP (1) EP0973744A1 (en)
JP (1) JP2001510478A (en)
KR (1) KR20000070756A (en)
CN (1) CN1252057A (en)
AU (1) AU730109B2 (en)
BG (1) BG103631A (en)
BR (1) BR9807181A (en)
CA (1) CA2279636A1 (en)
CZ (1) CZ279299A3 (en)
DE (1) DE19704243A1 (en)
HU (1) HUP0001022A2 (en)
ID (1) ID24208A (en)
IL (1) IL131127A0 (en)
NO (1) NO993738L (en)
NZ (1) NZ337011A (en)
PL (1) PL334899A1 (en)
SK (1) SK104099A3 (en)
TR (1) TR199901857T2 (en)
WO (1) WO1998034920A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2275091A1 (en) 2001-06-22 2011-01-19 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of an amorphous drug
ATE444060T1 (en) 2001-06-22 2009-10-15 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS CONTAINING DISPERSIONS OF MEDICINAL SUBSTANCES AND NEUTRAL POLYMERS
DE60320940D1 (en) 2002-02-01 2008-06-26 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DISPERSIONS OF ACTIVE SUBSTANCES AND LIPOPHILIC MICROPHASE-BASED MATERIALS
MXPA05009976A (en) 2003-03-17 2005-11-04 Japan Tobacco Inc Method for increasing the oral bioavailability of s-`2- (``1-(2- ethylbutyl) cyclohexyl! carbonyl! amino) phenyl!-2- methylpropanethioate.
CL2004001884A1 (en) 2003-08-04 2005-06-03 Pfizer Prod Inc DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS.
ATE540671T1 (en) 2003-08-04 2012-01-15 Bend Res Inc PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DRUG ADSORBATES AND LIPOPHILIC MICROPHASE-FORMING MATERIALS
JP4536061B2 (en) 2003-09-26 2010-09-01 日本たばこ産業株式会社 Method for inhibiting remnant lipoprotein production
DOP2005000123A (en) * 2004-07-02 2011-07-15 Merck Sharp & Dohme CETP INHIBITORS
WO2006032987A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Indoline compounds and their use in the treatment of arteriosclerosis
EP1844078B1 (en) 2005-02-03 2016-09-28 Bend Research, Inc Pharmaceutical compositions with enhanced performance
US20100113473A1 (en) 2008-10-30 2010-05-06 Player Mark R Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis

Also Published As

Publication number Publication date
CA2279636A1 (en) 1998-08-13
TR199901857T2 (en) 1999-10-21
NO993738L (en) 1999-09-17
AU6212398A (en) 1998-08-26
EP0973744A1 (en) 2000-01-26
CN1252057A (en) 2000-05-03
AU730109B2 (en) 2001-02-22
HUP0001022A2 (en) 2000-09-28
IL131127A0 (en) 2001-01-28
NZ337011A (en) 2001-04-27
BG103631A (en) 2000-11-30
KR20000070756A (en) 2000-11-25
WO1998034920A1 (en) 1998-08-13
JP2001510478A (en) 2001-07-31
DE19704243A1 (en) 1998-08-06
BR9807181A (en) 2000-01-25
ID24208A (en) 2000-07-13
SK104099A3 (en) 2000-01-18
PL334899A1 (en) 2000-03-27
CZ279299A3 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
NO970373D0 (en) Benzoxazoles and pyridine derivatives useful in the treatment of type II diabetes
DE60136736D1 (en) Pyrimidine derivatives and their use in the treatment of atherosclerosis
AU4171500A (en) Flupirtine in the treatment of fibromyalgia and related conditions
DE69925186D1 (en) Addition of glucosaminoglycans and their precursors in food
NO20002846L (en) Inhalation device and method of the same
NO2008012I2 (en) Dabigatran ethoxylate and its salts - especially dabigatran ethoxylate mesylate
NO20001323D0 (en) Dipeptide-apoptosis inhibitors and their use
NO993738D0 (en) 2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia
NO983576D0 (en) Well treatment fluids and methods
FI980246A0 (en) Method of using the kettle and kettle
DK91793A (en) Method of surface treatment, means of application and its use
DK0767666T3 (en) Methods and Preparations Useful in Prophylaxis and Treatment of Endotoxin-Related Conditions
NO20001412D0 (en) Compositions and Methods in the Treatment of Respiratory Disorders
NO991160D0 (en) Sulfate-containing polysaccharides and their applications in medical treatment
NO972426D0 (en) Method for the use of triarylethylene derivatives in the treatment and prevention of osteoporosis
NO20020031D0 (en) Dihydrobenzodiazepines and their use in the treatment of dyslipidemia
DK0898566T3 (en) Substituted benzylamines and their use in the treatment of depression
NO20011606L (en) Process for the cleaning and decontamination of polyesters
NO985806D0 (en) Chitinase Materials and Methods
NO20001758D0 (en) Methods and compositions for the treatment of arthritis
NO993102D0 (en) Chip card and method of using the chip card
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
NO992310D0 (en) Inhibitors and their use in oils
FI972468A (en) Locks that can be opened and closed from opposite sides
NO961733D0 (en) Procedure for disinfection and drying

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application